Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxandrolone for growth in infants with HLHS
NCT04090697Phase 2Terminated
- Sponsor
- Elevance Health
- Start
- Dec 2019
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of oxandrolone in Growth failure (FTT), sponsored by Elevance Health. Started Dec 2019; status: terminated.
02
Drugs
oxandrolone
03
Conditions
Growth failure (FTT)
Beyond the preview
Go deeper on NCT04090697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04090697.